Every Disease Has its Day
October 31, 2022
Is now finally the time for Alzheimer’s drug development to shine?
2 min read
October 2022
This issue, we warm up for our upcoming 2022 Innovation Awards with a look back at 2021’s Grand Winner and two runners up: a software system, a new form of smart connector, and new equipment for analytical science. Within its pages you’ll also find a cell and gene expert weighing the pros and cons of LLV and AAV viral vectors, and the new head of the Drugs for Neglected Diseases initiative explaining why we need to decolonize drug development. Further politically-minded commentary is on offer in an opinion piece arguing that pharma needs a disruptive “Elon Musk” figure to turn the field on its head.
From Viral Video to Magic Medicine
October 28, 2022
In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy
2 min read
De-Risking Your Sterile Manufacturing Program
October 21, 2022
Drug development program sponsors are increasingly looking to CDMOs to help reduce risk and push projects forward. With more than 40 years of experience, Alcami knows how to minimize risk at every single step of the development path.
6 min read
Let’s Get Closer
October 20, 2022
Post-COVID-19, the pharma industry has a better opportunity than ever before to get closer to the patient
4 min read
The Dual Sourcing Approach
October 20, 2022
How robust is your strategy? Are you prepared for supply chain interruption? In today’s turbulent world, risk mitigation strategies are a must – and having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines is no longer a ‘nice to have’. It should be an essential part of your strategy in terms of patient health.
1 min read
Working Together to Unlock Innovation
October 10, 2022
How incumbent pharma can learn and benefit from disruptive entrepreneurs
10 min read
Discovery & Development
Bioprocessing
Biopharma
Facilities & Equipment
Technology & Manufacturing
Business & Trends
The Cutting Edge of Biopharma Analytics
August 30, 2022
How can new analytical tech help biopharma manufacturers? We speak with one of our Innovation Award runners up
7 min read
Getting to Grips with the E&L Threshold
August 10, 2022
Did you know the PQRI has released new recommendations on extractables and leachables in parenteral drug products?
8 min read
The Grand Challenge: Oligonucleotides Under the Microscope
August 9, 2022
Though highly customizable and therapeutically relevant, manufacturing challenges could pose setbacks for the growth of the oligonucleotide drug market. How, if at all, can they be overcome?
5 min read
Champions of Cell and Gene Therapy
July 20, 2022
How do we ensure that not only the rich benefit from cell and gene therapy?
7 min read
Getting Smarter with Small Molecule Discovery: Lessons Learned With Tom Mander
July 19, 2022
The search for new small molecule therapeutics is becoming increasingly difficult as companies focus on more challenging targets. Tom Mander, Chief Executive Officer of Domainex, looks back on his career in small molecules and shares his hopes for the future – including how small molecules may finally be able to provide a breakthrough in Parkinson’s disease.
17 min read
You Shouldn’t Need a Spoonful of Sugar
July 14, 2022
If companies truly aim to achieve patient-centricity, they must embrace the importance of taste masking
3 min read
